Tag: six months

SIGMA LITHIUM REPORTS 2Q25 RESULTS: DELIVERS ON-TARGET PRODUCTION, FURTHER COST REDUCTIONS AND DELEVERAGING

HIGHLIGHTS Achieved 68,368t of lithium oxide concentrate in 2Q25, a 38% year-on-year increase and slightly above the quarterly target of 67,500t.Maintained cost under control and...

SIGMA LITHIUM REPORTS 2Q25 RESULTS: DELIVERS ON-TARGET PRODUCTION, FURTHER COST REDUCTIONS AND DELEVERAGING

HIGHLIGHTS Achieved 68,368t of lithium oxide concentrate in 2Q25, a 38% year-on-year increase and slightly above the quarterly target of 67,500t.Maintained cost under control and...

Vertex Resource Group Ltd. Reports Second Quarter 2025 Results

SHERWOOD PARK, AB, Aug. 14, 2025 /CNW/ - (TSXV: VTX) - Vertex Resource Group Ltd. ("Vertex" or the "Company") reports its financial and operational...

Carbon Streaming Announces Financial Results for the Three and Six Months Ended June 30, 2025

Carbon Streaming Announces Financial Results For The Three And Six Months Ended June 30, 2025

Conrad Industries Announces Second Quarter 2025 Results and Backlog

MORGAN CITY, La., Aug. 14, 2025 /PRNewswire/ -- Conrad Industries, Inc. (OTC Pink: CNRD) announced today its second quarter and six months ended June 30,...

YXT.com to Announce Financial Results for the First Six Months of 2025 on August 20, 2025

SUZHOU, China, Aug. 14, 2025 (GLOBE NEWSWIRE) -- YXT.com Group Holding Limited (NASDAQ: YXT) (“YXT.com” or the “Company”), a provider of AI-enabled enterprise productivity solutions in China, today announced that it plans to report its financial results for the first six months ended June 30, 2025, before the U.S. market opens on August 20, 2025.

Pediatric Relapsed/Refractory Neuroblastoma Market is on an Upward Trend, Driven by Innovation and Unmet Need | DelveInsight

The outlook for the neuroblastoma treatment market is optimistic, fueled by progress in targeted therapies and immunotherapies. GD2-targeted immunotherapy is increasingly being incorporated into...

Pediatric Relapsed/Refractory Neuroblastoma Market is on an Upward Trend, Driven by Innovation and Unmet Need | DelveInsight

The outlook for the neuroblastoma treatment market is optimistic, fueled by progress in targeted therapies and immunotherapies. GD2-targeted immunotherapy is increasingly being incorporated into...

INVO Fertility Announces Second Quarter 2025 Financial Results

SARASOTA, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation of fertility clinics and related businesses and technologies, today announced second quarter 2025 financial results.

Melcor Developments announces second quarter results, declares quarterly dividend of $0.13 per share

EDMONTON, Alberta, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Melcor Developments Ltd. ("Melcor") (TSX: MRD), an Alberta-based real estate development and asset management company, today reported results for the second quarter ended June 30, 2025. The second quarter Management Discussion & Analysis (MD&A) and Condensed Interim Financial Statements are available on our website (www.melcor.ca) under Investors, or on SEDAR+ (www.sedarplus.ca).

Automotive Properties REIT Announces 2025 Second Quarter Financial Results, Agreements to Acquire Seven Automotive Properties and Distribution Increase

TORONTO, Aug. 14, 2025 /CNW/ - Automotive Properties Real Estate Investment Trust (TSX: APR.UN) ("Automotive Properties REIT" or the "REIT") today announced its financial results...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsSix months

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Veritone, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VERI

PHREESIA DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Phreesia, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PHR

Attorney John Gomez Announces Whistleblower Retaliation Lawsuit on Behalf of Former Albert Einstein Academies Principal

Tag: six months

SIGMA LITHIUM REPORTS 2Q25 RESULTS: DELIVERS ON-TARGET PRODUCTION, FURTHER COST REDUCTIONS AND DELEVERAGING

SIGMA LITHIUM REPORTS 2Q25 RESULTS: DELIVERS ON-TARGET PRODUCTION, FURTHER COST REDUCTIONS AND DELEVERAGING

Vertex Resource Group Ltd. Reports Second Quarter 2025 Results

Carbon Streaming Announces Financial Results for the Three and Six Months Ended June 30, 2025

Conrad Industries Announces Second Quarter 2025 Results and Backlog

YXT.com to Announce Financial Results for the First Six Months of 2025 on August 20, 2025

Pediatric Relapsed/Refractory Neuroblastoma Market is on an Upward Trend, Driven by Innovation and Unmet Need | DelveInsight

Pediatric Relapsed/Refractory Neuroblastoma Market is on an Upward Trend, Driven by Innovation and Unmet Need | DelveInsight

INVO Fertility Announces Second Quarter 2025 Financial Results

Melcor Developments announces second quarter results, declares quarterly dividend of $0.13 per share

Automotive Properties REIT Announces 2025 Second Quarter Financial Results, Agreements to Acquire Seven Automotive Properties and Distribution Increase

G Mining Ventures Reports Strong Q2 2025 Results

Orca Energy Group Inc. Announces Completion of Q2 2025 Interim Filings

FSI ANNOUNCES SECOND QUARTER, 2025 FINANCIAL RESULTS

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us